FORPENEM-300
General Range

FORPENEM-300

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FORPENEM-300 Tablets by Fortune Labs contain Faropenem Sodium 300 mg, an oral beta-lactam antibiotic formulated for treating selected bacterial infections caused by susceptible microorganisms. Faropenem works by inhibiting bacterial cell wall synthesis, helping control bacterial growth and infection. FORPENEM-300 may be prescribed for certain respiratory tract infections, urinary tract infections, and skin infections when clinically appropriate. Its extended-release formulation is designed to provide controlled drug release. Available in convenient blister packaging, this product is part of Fortune Labs' antibiotic pharmaceutical portfolio. Fortune Labs offers Antibiotic PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. Use strictly under medical supervision to ensure responsible antibiotic treatment.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Faropenem Sodium 300 mg
Packaging Type
Blister Pack with Outer Carton
Packaging Size
10 × 1 × 6
Dosage Form
Tablet
Treatment
Blister Pack with Outer Carton
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range

WhatsApp us